Location: Home
  • search
  • go
  • Relate News
  • 2/26/2020FDA Catches Lies and Violations of Chinese Heparin Producer Yibin Liha...
  • 2/26/2020McKinsey Assesses Impacts of Covid-19 on China Healthcare
  • 2/26/2020Snapshot of 11 Biopharma Cos Seeking IPOs at Shanghai’s Star Board
  • 2/26/2020PhIRDA Advocates the Establishment of CEUA System for Drug Authorizati...
  • 2/26/2020China Issues New Policy to Strengthen Pharmacy Affairs and Drug Ration...
  • 2/26/2020Vir Biotech and WuXi Biologics Partners to Develop mAbs for Covid-19 T...
  • 2/26/2020MabPlex Launches Two New Cell Culture Production Lines
  • 2/26/2020US Initiates First Study of Gilead's Remdesivir for Coronavirus Treatm...
  • 2/26/2020Gilead's Antiviral Remdesivir Granted Three Patents in China
  • 2/26/2020APEIRON's Respiratory Drug to Start Pilot Trial for Covid-19 in China
  • 2/25/2020EPO and CNIPA Announce Pilot Programme to Enhance PCT Co-operation
  • 2/25/2020Gilead JV's NDA for CAR-T Cancer Therapy Accepted in China
  • 2/25/20202019 Ends and 2020 Begins with a Flurry of Biosimilar Activity in East...
  • 2/25/2020Almirall and Paratek Enter into a License Agreement for Seysara in Chi...
  • 2/25/2020Ascentage Pharma Approved for Phase Ib/II Trial of IAP Inhibitor APG-1...
  • 2/25/2020Medivir and SJZ Yuanmai Biotech Enter Licensing Pact for Herpes Drug X...
  • 2/24/2020Sanofi to Compete in API Sector against China and India with New Compa...
  • 2/24/2020GSK Ties Up with China's Clover Biopharma in Coronavirus Vaccine Devel...
  • 2/24/2020China Issues New Policy to Reduce Urban Employee BMI Premium Contribut...
  • 2/24/2020China Begins Animal Testing of First Novel Coronavirus Vaccines
  • 2/24/2020Wuxi Vaccines Inks $3B Manufacturing Deal with 'Global Vaccine Leader'
  • 2/21/2020Recent Executive Moves
  • 2/21/2020WHO: Early Trial Results for Coronavirus Treatments Expected in 3 week...
  • 2/21/2020Chinese Foundation Grants $2.1M to Columbia Researchers to Find Antivi...
  • 2/20/2020Wuxi AppTec Eyes U.S. Expansion amid Chinese Facilities Disruptions
  • 2/20/2020Jinghua Pharma Drops Development of Two mAbs Licensed from Kadmon
  • 2/20/2020Vifor Pharma and Fresenius Kabi Create JV in China for IV Iron Portfol...
  • 2/20/2020Pharma and MedTech Outlook Clouded by Coronavirus Outbreak
  • 2/20/2020Teva Pharm Eyes Launch of Huntington's Drug in China This year
  • 2/20/2020U.S. FDA Suspends China Inspections, Warns of Potential Shortages
  • Page:192/719 Total number of articles:21568: [First][<<] [190] [191] [192] [193] [194] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group